Sufentanil Citrate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Sufentanil Citrate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on May 3, 2022. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-3382-21
- Dosage Form
- Injection
- Presentation
- Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)
- Initial Posting
- May 3, 2022
Reason
Other